Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06071884 · ClinicalTrials.gov registry record · NA

Bridge Device for Surgical Pain for Rotator Cuff Surgery

A NA study of Pain and Rotator Cuff Injuries, sponsored by Steven Orebaugh.

Completed
Registry status
NA
Development phase
42
Enrollment target
1
Study location

NCT06071884 is a NA study of Pain and Rotator Cuff Injuries that has completed, run by Steven Orebaugh. The registered enrollment target is 42 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06071884, a NA study of Pain and Rotator Cuff Injuries, has completed, sponsored by Steven Orebaugh.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

The objective of the trial is to investigate the efficacy of the Bridge device in reducing post-operative pain and post-operative opioid consumption in patients undergoing rotator cuff surgery with the typical mode of anesthesia, nerve block plus propofol sedation.

Interventions

  • DEVICE Bridge Percutaneous Nerve Field Stimulator

Study Locations (1)

Pennsylvania

  • UPMC Outpatient Center - West Mifflin

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2024-07-29
Est. Completion 2024-09-26
Phase NA

Sponsor

Steven Orebaugh

2 total trials

What the Registry Record Tells You About NCT06071884

The ClinicalTrials.gov registry entry for NCT06071884 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (86% lower). The listed sponsor is Steven Orebaugh, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Bridge Percutaneous Nerve Field Stimulator is the first listed.

NCT06071884 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06071884 about?

NCT06071884 is a clinical study titled "Bridge Device for Surgical Pain for Rotator Cuff Surgery". The objective of the trial is to investigate the efficacy of the Bridge device in reducing post-operative pain and post-operative opioid consumption in patients undergoing rotator cuff surgery with the typical mode of anesthesia, nerve block plus propofol sedation.

What is the current status of trial NCT06071884?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2024-07-29. Estimated completion is 2024-09-26.

What conditions does trial NCT06071884 study?

This clinical trial studies the following conditions: Pain, Rotator Cuff Injuries.

What interventions are being tested in trial NCT06071884?

The interventions under investigation include: Bridge Percutaneous Nerve Field Stimulator (DEVICE).

Who is sponsoring clinical trial NCT06071884?

This trial is sponsored by Steven Orebaugh, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06071884 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.